Alembic Pharmaceuticals Limited — Board Meeting, 15-05-2026: Outcome of Board Meeting

Alembic Pharma's board approved full-year consolidated financial results for FY26, reporting Revenue from Operations of Rs 7,344.90 Cr & Net Profit of Rs 674.77 Cr. The board also proposed a Rs 12/share dividend (600%).